Your browser doesn't support javascript.
loading
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
Naik, Seema; Riches, Marcie; Hari, Parameswaran; Kim, Soyoung; Chen, Min; Bachier, Carlos; Shaughnessy, Paul; Hill, Joshua; Ljungman, Per; Battiwalla, Minoo; Chhabra, Saurabh; Daly, Andrew; Storek, Jan; Ustun, Celalettin; Diaz, Miguel Angel; Cerny, Jan; Beitinjaneh, Amer; Yared, Jean; Brown, Valerie; Page, Kristin; Dahi, Parastoo B; Ganguly, Siddhartha; Seo, Sachiko; Chao, Nelson; Freytes, Cesar O; Saad, Ayman; Savani, Bipin N; Woo Ahn, Kwang; Boeckh, Michael; Heslop, Helen E; Lazarus, Hillard M; Auletta, Jeffery J; Kamble, Rammurti T.
Afiliação
  • Naik S; Penn State Cancer Institute, Hershey, Pennsylvania.
  • Riches M; Division of Hematology/Oncology, The University of North Carolina, Chapel Hill, North California.
  • Hari P; Department of Medicine, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin.
  • Kim S; Department of Medicine, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin.
  • Chen M; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bachier C; Department of Medicine, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin.
  • Shaughnessy P; Sarah Cannon Center for Blood Cancer, Nashville, Tennessee.
  • Hill J; Texas Transplant Institute, Sarah Cannon Blood Cancer Network, San Antonio, Texas.
  • Ljungman P; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Battiwalla M; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden.
  • Chhabra S; Sarah Cannon Center for Blood Cancer, Nashville, Tennessee.
  • Daly A; Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Storek J; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Ustun C; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Diaz MA; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, Minnesota.
  • Cerny J; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Beitinjaneh A; UMass Memorial Medical Center, Worcester, Massachusetts.
  • Yared J; University of Miami, Miami, Florida.
  • Brown V; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland.
  • Page K; Division of Pediatric Oncology/Hematology, Department of Pediatrics, Penn State Hershey Children's Hospital and College of Medicine, Hershey, Pennsylvania.
  • Dahi PB; Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina.
  • Ganguly S; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Seo S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Chao N; Department of Hematology, Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Freytes CO; Division of Cell Therapy and Hematologica, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Saad A; Texas Transplant Institute, Sarah Cannon Blood Cancer Network, San Antonio, Texas.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Woo Ahn K; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Boeckh M; Department of Medicine, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin.
  • Heslop HE; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Lazarus HM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Auletta JJ; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Kamble RT; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
Transpl Infect Dis ; 21(5): e13145, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31301099
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Infecções por Vírus Epstein-Barr / Transtornos Linfoproliferativos Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Condicionamento Pré-Transplante / Infecções por Vírus Epstein-Barr / Transtornos Linfoproliferativos Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article